Login / Signup

Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome.

Sue M HusonTimo StaabMarta PereiraHeather WardRoberto ParedesD Gareth EvansDaniel BaumhoerJames O'SullivanEd CheesmanDetlev SchindlerStefan Meyer
Published in: Familial cancer (2020)
Bloom syndrome (BS) is a genomic and chromosomal instability disorder with prodigious cancer predisposition caused by pathogenic variants in BLM. We report the clinical and genetic details of a boy who first presented with infantile fibrosarcoma (IFS) at the age of 6 months and subsequently was diagnosed with BS at the age of 9 years. Molecular analysis identified the pathogenic germline BLM sequence variants (c.1642C>T and c.2207_2212delinsTAGATTC). This is the first report of IFS related to BS, for which we show that both BLM alleles are maintained in the tumor and demonstrate a TPM3-NTKR1 fusion transcript in the IFS. Our communication emphasizes the importance of long-term follow up after treatment for pediatric neoplastic conditions, as clues to important genetic entities might manifest later, and the identification of a heritable tumor predisposition often leads to changes in patient surveillance and management.
Keyphrases
  • copy number
  • case report
  • genome wide
  • dna methylation
  • public health
  • squamous cell
  • childhood cancer
  • rna seq
  • squamous cell carcinoma
  • dna damage
  • oxidative stress
  • single cell